lundi 2 mars 2015

FDA decision on nerve block

It's nice to see the FDA wasn't fooled by Pacira shenanigans .....Exparel is an expensive 24 hour marcaine. It's been the case since the launch: little benefit after 1 day. Little to no reduction in need for other pain meds. Why would this ever get approved in nerve block....





FDA decision on nerve block

Aucun commentaire:

Enregistrer un commentaire